Discussion and Q&A - ERS Respiratory Channel

Novel research impacting clinical practice in interstitial lung disease

Chair(s): Wim A. Wuyts, Athina Trachalaki

Session type: Oral presentation

Discussion and Q&A

EVENTS HOME

Replay

Previous presentation

Next presentation

Session content

Late Breaking Abstract - Safety, tolerability and antifibrotic activity of bexotegrast: Phase 2a INTEGRIS-IPF study (NCT04396756)

Wim A. Wuyts

Replay

Poster

Abstract

Slides

Nationwide All ILD registry with central MDD in Japan; Providing Multidisciplinary ILD diagnoses (PROMISE) study.

Taiki Furukawa

Replay

Poster

Abstract

Slides

Experience of making early interstitial lung disease diagnosis from patients taking part in UK national pilot lung screening programme.

Daniel Trushell-pottinger

Replay

Poster

Abstract

Slides

Use of 1.1-mm probes in transbronchial lung cryobiopsy for diagnosing interstitial lung diseases: a randomized trail

Gang Hou

Replay

Poster

Abstract

Slides

Electronic nose technology differentiates interstitial lung diseases from other chronic respiratory diseases

Iris G. Van Der Sar

Replay

Poster

Abstract

Slides

Development and validation of a nomogram for predicting pulmonary complications after curative resection in idiopathic pulmonary fibrosis patients with early stage lung cancer

Yunjoo Im

Replay

Abstract

Slides

Telemedicine in patients with Idiopathic Pulmonary Fibrosis

Matteo Davi

Replay

Poster

Abstract

Slides

The clinical frailty scale is associated with progression of fibrotic interstitial lung disease a multicentre cohort study.

Sabina A. Guler

Replay

Poster

Abstract

Slides

Patient reported assessment of swallowing and throat symptoms and reflux in patients with idiopathic pulmonary fibrosis

Amal Alamer

Replay

Abstract

Slides

Buccal microbiome and survival in idiopathic pulmonary fibrosis: CleanUP-IPF

John Kim

Replay

Poster

Abstract

Slides

Discussion and Q&A

Replay

The ERS International Congress 2023, Milan

#{title}